New treatment may hold key to diabetes cure

Bs_logoImage
Press Trust of India Washington
Last Updated : May 30 2013 | 5:21 PM IST
A new treatment that uses an injection of adult stem cells from bone marrow in combination with a drug may provide a cure for diabetes, scientists claim.
"We discovered that type 1 diabetes destroys not only insulin-producing cells but also blood vessels that support them," said lead researcher Habib Zaghouani from the University of Missouri.
"When we realised how important the blood vessels were to insulin production, we developed a cure that combines a drug we created with adult stem cells from bone marrow.
"The drug stops the immune system attack, and the stem cells generate new blood vessels that help insulin-producing cells to multiply and thrive," he said.
In previous studies, Zaghouani and his team developed a drug against type 1 diabetes called Ig-GAD2. They found that treatment with the drug stopped the immune system from attacking beta cells, but too few beta cells survived the attack to reverse the disease.
In his latest study on mice, Zaghouani used Ig-GAD2 and then injected adult stem cells from bone marrow into the pancreas in the hope that the stem cells would evolve into beta cells.
"The combination of Ig-GAD2 and bone marrow cells did result in production of new beta cells, but not in the way we expected," Zaghouani said.
"We thought the bone marrow cells would evolve directly into beta cells. Instead, the bone marrow cells led to growth of new blood vessels, and it was the blood vessels that facilitated reproduction of new beta cells.
"In other words, we discovered that to cure type 1 diabetes, we need to repair the blood vessels that allow the subject's beta cells to grow and distribute insulin throughout the body," he said.
Zaghouani is pursuing a patent for his promising treatment and hopes to translate his discovery from use in mice to humans.
"Our discovery about the importance of restoring blood vessels has the potential to be applied not only to type 1 diabetes but also a number of other autoimmune diseases," he added.
The study was published in the journal Diabetes.
Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories

  • Over 30 subscriber-only stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 30 2013 | 5:21 PM IST